Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial. - Ozer BH; Lindhorst SM; Merrell RT; Trevino CR; Rudnick JD; Avgeropoulos NG; Ramakrishna N; Khagi S; Rauf Y; Walbert T; Pan E; Youssef M; et al. (MedRxiv : the preprint server for health sciences, 2026)